Craftsman Automation Credit Rating

Craftsman Automation Earnings Call Transcript: Key Takeaways

Management projects robust growth despite temporary margin compression in aluminum and higher debt levels.

Call

Guides 15% growth

Craftsman Automation Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹2,945 Cr (+47% YoY), EBITDA ₹412 Cr (+32%), PAT ₹153 Cr (+68%). H1 revenue ₹5,377 Cr (+42%). EBITDA margin compressed; no explicit guidance given.

Craftsman Automation Other Announcement

Craftsman Automation filed a Regulation 32 statement reporting no deviation in its ₹2,000 crore QIP utilisation. Funds were fully deployed for the intended objects, ending further filing obligations.

Craftsman Automation Q2 FY27 Results: Net Profit ₹153.2 Cr, Up 68.5% YoY

Craftsman Automation Ltd reported revenue from operations of ₹2,945 Cr (+47.1% YoY) and net profit of ₹153.2 Cr (+68.5% YoY) for Q2 FY27.

Key figure

Net profit ₹153.2 Cr · +68.5% YoY

Craftsman Automation Other Announcement

Craftsman Automation Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes disclosures regarding the transmission of shares of a deceased promoter.

Craftsman Automation Board Meeting Date

Craftsman Automation intimated that its board meeting is scheduled for 28 October 2026 to approve Q1 and H1 FY27 unaudited results. Trading window is closed from 1 October 2026 until 48 hours post-results.

Singer India Credit Rating

Singer India's Rs.45 Crore bank facilities were re-rated by CRISIL. Long-term stayed BBB-/Stable while the short-term rating was upgraded to Crisil A3+.

Bondada Engineering Credit Rating

CRISIL upgraded credit ratings for five subsidiaries of Bondada Engineering to A/Stable or A-/Stable. The upgrade reflects strong financials and supports the group's lender credibility.

20 Microns Credit Rating

CRISIL reaffirmed 20 Microns' bank loan ratings at A/Stable and A1 on ₹117 crore facilities. Ratings remain unchanged from prior assessment.

Epigral Credit Rating

CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.

Mankind Pharma Credit Rating

CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.

Lloyds Metals & Energy Credit Rating

Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.